Therefore, our results suggest that the bioactive constituent of Aloe perryi extracts could serve as a targeted therapy for estrogen receptor α positive breast cancer or androgen receptor prostate cancer, which warrant further research and investigations [46]. This evidence concerns the gene ESR1 and prostate cancer.